Euro Nephrology Conference Market Analysis and Reports | Spain Conference Series

Market Analysis - Euro Nephrology Conference 2017

Market Analysis

Summary of Nephrology Conference (Overall Market of Nephrology with   Statistics)

According to the recent statistics in Spain the kidney disease deaths is reached to7,085 or 25.3% of total deaths. The morality rate in Spain for kidney diseases is 6.2. In the world, every year at least 2.3 million people may have died because of kidney failure. In 2030 number of people receiving dialysis or kidney transplantation set to more than double to over 5 million. In USA every 1 in 3 adults is currently at risk for developing kidney diseases. The 9th leading cause of deaths in USA is kidney disease. In USA 6 lakh deaths are due to kidney diseases. It is being acknowledged that throughout USA more than 17,105 kidney transplantations took place in 2014 alone. In 2015, 11,570 came from deceased donors and 5,535 came from living donors. Every day 12 people die while waiting for a life-saving kidney transplant. For every 14 minutes an individual is added to the renal transplant list. In 2014, 4,270 patients died due to increasing the lag time for a kidney transplant. Another, 3,617 people became too sick to take delivery of kidney transplant. Medical Expenditures for individual patient per year with kidney disease increase from $15,000 in stage 3 to $28,000 in stage 4 to more than $ 70,000 in stage 5. Every year, Medicare spent nearly $ 28.6 billion to treat people with kidney failure. National kidney Foundation has provided more than $100 million for research. Annually US spent $ 41 billion or 17% of their Medicare budget on people with kidney diseases.

 

 

Conference Highlights

Nephrology

Etiology and Pathogenesis of Kidney Diseases

Kidney and Bladder Stones

Acute Kidney Injury

Chronic Kidney Diseases

End Stages Renal diseases

Glomerular Disorders

Kidney cancer

Hypertension Associated with Kidney Diseases

Diabetic Nephropathy

Pediatric Nephrology

Clinical Nephrology

Kidney Replacement Therapy

Kidney Transplantation

Advancements in the Treatment of Kidney diseases

Drugs used in the treatment of kidney diseases

Scope and Importance of  Nephrology Research

The Society of Nephrology represents a wide international network and provides an efficient platform for timely scientific exchange, debate and dissemination between healthcare professionals around the world. It is also dedicated to addressing the disparity between the developing and developed worlds in the research, diagnosis, treatment, and prevention of kidney disease. In the United States of America, the National Kidney Foundation is an organization set up for nephrology and nephrologists. In 1966, the American Society of Nephrology (ASN) was founded that forms world’s largest professional society dedicated to nephrology. The American Society of Nephrology (ASN) leads the fight against kidney disease by educating health professionals, sharing new knowledge, advancing research, and advocating the highest quality. In the United Kingdom, the National Kidney Federation and the Renal Association are dedicated to nephrology.

Nephrology concerns the diagnosis and treatment of kidney diseases, including electrolyte disturbances and hypertension, and the care of those requiring renal replacement therapy, including dialysis and renal transplant patients. Many diseases affecting the kidney are systemic disorders not limited to the organ itself, and may require special treatment. Nephrologists may further sub-specialise in dialysis, kidney transplantation, chronic kidney disease, cancer-related kidney diseases (Onconephrology), procedural nephrology or other non-nephrology areas as described above. Patients are referred to nephrology specialists after a urinalysis, for various reasons, such as acute kidney failure, chronic kidney disease, hematuria, proteinuria, kidney stones, hypertension, and disorders of acid/base or electrolytes Procedures a nephrologist may perform include native kidney and transplant kidney biopsy, dialysis access insertion (temporary vascular access lines, tunnelled vascular access lines, peritoneal dialysis access lines), fistula management (angiographic or surgical fistulogram and plasty), and bone biopsy

Why it’s in Barcelona, Spain

Barcelona is one of the world's leading tourist, economic, trade fair and cultural centres, and its influence in commerce, education, entertainment, media, fashion, science, and the arts all contribute to its status as one of the world's major global cities. It is a major cultural and economic centre in south western Europe, 24th in the world (before Zürich, after Frankfurt) a financial centre. Barcelona is the capital city of the autonomous community of Catalonia in the Kingdom of Spain, as well as the country's second most populous municipality, with a population of 1.6 million within city limits. Its urban area extends beyond the administrative city limits with a population of around 4.7 million people,being the sixth-most populous urban area in the European Union after Paris, London, Madrid, the Ruhr area and Milan

According to the recent statistics the 10th leading cause of deaths in Spain is kidney diseases. The kidney diseases rate in Spain is 6.2.The 10% of population in world is affected by chronic kidney diseases. According to the recent statistics the 21.12% or 2,552 kidney transplants are performed in Spain. Every year, kidney disease kills more people than breast or prostate cancer. For every 14 minutes an individual is added to the renal transplant list. Every day, 12 people die waiting for a kidney. So, professionally-oriented education in Nephrology is essential in the training of clinicians and academicians and organizes Nephrology-2017 conference in Barcelona, Spain.

Members Associated with Nephrology Research

Nephrologists

Pediatric Nephrology

Fellows or postdoctoral students

Nephrology Academicians

Students pursuing an MD or PhD

Emeritus

Young research scientists

Business delegates

 

Hospitals Associated with Nephrology Research

Spain

MADRID'S La Paz University Hospital 

Valencia's La Fe hospital 

Hospital Clinic i Provincial de Barcelona

HM Hospitales

Vithas Xanit International Hospital

Nisa Pardo de Aravaca Hospital

Hospital General de Catalunya

Sant Joan de Déu-Barcelona Children’s Hospital

Quirón Madrid University Hospital

Grupo Hospitalario Quirón

Europe

Klinik Hirslanden, Zurich

Klinik Im Park, Zurich

Health Centre Bad Ragaz

Klinik Pyramide Am See

Klinik Beau-Site, Berne

Hirslanden Clinique La Colline

Lucerne Health

Salem-Spital, Berne

Hirslanden Klinik Aarau

J.W. Goethe University Hospital

World

Mayo Clinic

Cleveland Clinic

New York-Presbyterian University Hospital of Columbia and Cornell

UCSF Medical Center

Brigham and Women's Hospital

Johns Hopkins Hospital

Massachusetts General Hospital

UCLA Medical Center

Duke University Hospital

Vanderbilt University Medical Center

Societies Associated with Nephrology Research

Spain

Spanish Society of Nephrology

Spanish Dialysis and Transplant Society

Spanish Dialysis Foundation

Europe

Danish Society of Nephrology

Swedish Society of Nephrology

British Association of Pediatric Nephrology

French Society of Nephrology

Polish Society of Nephrology

Albanian Society of Nephrology

Belgian Society of Nephrology

Austrian Society of Nephrology

German Society of Nephrology

The Renal Association (UK)

Global

International Society of Nephrology (ISN) Gateway

 American Society of Nephrology

The Philippine Society of Nephrology

Canadian society of nephrology

Kidney Disease Association‎

The National Kidney Foundation

Chronic Kidney Disease - World Kidney Day

Clinical Journal of the American Society of Nephrology

Indian society of nephrology

Renal association

The Asian Pacific Society of Nephrology

Emirates medical association on nephrology society

Industries Associated with Nephrology Research

Spain

Svenska Cellulosa Aktiebolaget SCA

Coloplast

Fresenius Medical Care AG & Co. KGaA

Baxter International Inc.

Hartmann Group

ONTEX International N.V.

First Quality Enterprises, Inc.

B. Braun Melsungen AG

Astra Tech Inc.

Kimberly-Clark Corporation

Covidien plc

Bellco Srl

Europe

Biocon

Kaneka Pharma Company

NxStage Medical, Inc.

Storz Medical AG

Siemens Healthcare

EDAP TMS S.A

Dornier MedTech GmbH

Nikkiso CO., LTD.

Teleflex Incorporated

Medline Industries, Inc.

Asahi Kasei Corporation

Global

Amgen

Astellas

Baxter International Inc.

DaVita HealthCare Partners Inc.

Amerisourcebergen

Genentech

Keryx Biopharmaceuticals, Inc.

Mallinckrodt Pharmaceuticals 

Anthem Biopharma

Sandor

Janssen Biotech,inc

Universities Associated with Nephrology Research

Spain

Universities in Spain

University of Navarra

University of Barcelona

University Complutense Madrid

Europe

University of Oxford

University of Cambridge

Imperial College London

University College London

University of Manchester

University of Barcelona

University of Glasgow

University of Oslo

Global

Stanford University

University of Michigan

Yale school of medicine

University of Washington

University of Wisconsin

Budapest Nephrology School

Description: http://annualmeeting.conferenceseries.com/upload-images/nephrologists2016-27190.png

Market Value on Nephrology Research

Spain

According to the recent statistics in Spain the kidney disease deaths is reached to7,085 or 25.3% of total deaths. In USA every 1 in 3 adults is currently at risk for developing kidney diseases. The 9th leading cause of deaths in USA is kidney disease. It is being acknowledged that throughout USA more than 17,105 kidney transplantations took place in 2014 alone. In 2015, 11,570 came from deceased donors and 5,535 came from living donors. Every day 12 people die while waiting for a life-saving kidney transplant. For every 14 minutes an individual is added to the renal transplant list. In 2014, 4,270 patients died due to increasing the lag time for a kidney transplant. Another, 3,617 people became too sick to take delivery of kidney transplant.

World

According to recent statistics report, nearly 26 million adults apart from young and old aged people are suffering from Chronic Kidney Disease complaints and millions of others are at increased risk. Medical Expenditures per patient per year with kidney disease increase from $15,000 in stage 3 to $28,000 in stage 4 to more than $70,000 in stage 5. Every year Medicare spent nearly $28.6 billion to treat people with kidney failure. National kidney Foundation has provided more than $100 million for research. Annually US spent $41 billion or 17% of their medicare budget on people with kidney diseases. The numbers of Kidney transplantations are seemingly very high and in the year of 2013 alone, there are around 15000 kidney transplantations. Being one of the major fields of Internal Medicine, Nephrological research received a funding of more than 5 billion dollars annually across the globe. Nearly $ 560 million is being funded on Kidney diseases alone per year due to the rapid increase for the risk of renal disorders.

Market Growth of  Nephrology Research in the last and upcoming ten years

In 2011, the market value for nephrology at USD 13.3 billion, and it is expected to reach an estimated value of USD 20.5 billion in 2018, growing at a CAGR of 6.4% from 2012 to 2018. According to WHO, more than 190 million patients suffering from chronic renal failure undergo renal dialysis In 2011, total Medicare spending was $549.1 billion, and of that, costs for kidney failure were $34.3 billion, or 6.2% of the total Medicare budget. Annually US spent $41 billion or 17% of their medicare budget on people with kidney diseases. Approximately coming 5 years it is increased to $52 billion for kidney diseases Approximately 17,000 kidney transplants are performed annually, yet the American waiting list for lifesaving kidney transplants includes 95,000 individuals. 

Description: http://annualmeeting.conferenceseries.com/upload-images/nephrologists2016-31771.png

Description: http://annualmeeting.conferenceseries.com/upload-images/nephrologists2016-64738.png

Products manufactured by the industry related Nephrology Research 

Global-2014

Auryxia (Ferric citrate); Keryx Biopharma

Harvoni (ledipasvir and sofosbuvir); Gilead

Viekira Pak (ombitasvir, paritaprevir, ritonavir and dasabuvir) tablets; Abbvie

2013

Procysbi (cysteamine bitartrate); Raptor Pharmaceuticals

Injectafer (ferric carboxymaltose injection); Luitpold Pharmaceuticals

2012

Afinitor (everolimus); Novartis

Inlyta (axitinib); Pfizer

Myrbetriq (mirabegron)

Omontys (peginesatide); Affymax

Stendra (avanafil); Vivus

Stivarga (regorafenib); Bayer HealthCare Pharmaceuticals

Voraxaze (glucarpidase); BTG International

2011

Anturol (oxybutynin) Gel; Antares Pharma

Nulojix (belatacept); Bristol-Myers Squibb

Soliris (eculizumab); Alexion

USA

Aranesp® — U.S

Sensipar® — U.S

Products-globally

Catheter Guidewires

Single Lumen Femoral Catheter

Haemodialysis Double Lumen Catheter

Haemodialysis Triple Lumen Catheter Kit

Haemodialysis Catheter Kit Double Lumen

Transducer Protector

Fistula Needle

Biopsy Needle Manual

Hand Control Pencil

Nitinol core wire

Dialysis Catheter

Disposable Fistula Needle

Pediatric Protector

Pediatric Transducer

Femoral Catheter

Haemodialysis Catheter

AV Fistula Needle

Biopsy Gun

Fund Allotment to Nephrology Research

Spain

Salvation Army - $2.08 billion- year-to-year 10.3% increase

European Living Donor Psychosocial Follow-up- Funding: 1.4 €. Source: Spanish Society of Nephrology.

Task Force for Global Health- $1.57 billion- 5.2% drop in donations.

Metabolic changes in peritoneal dialysis- Funding: 2.600 €. Source: UMIB/FCT.

Europe

Simultaneous kidney-pancreas transplantation- 24.000 €- Source: Department of Nephrology from Centro Hospitalar do Porto

 Nephropatic hereditary amyloidosis- Funding: 2.000 €- Source: Portuguese Society of Nephrology and Funding: 2.100 €. Source: UMIB/FCT

Uremia and functional-structural peritoneal membrane changes- Funding: 25.000 €. Source: Portuguese Society of Nephrology.

Global

 Feeding America- $1.86 billion- up 22.8% from a year earlier.

Salvation Army - $2.08 billion- year-to-year 10.3% increase

Predictive factors of long-term dysfunction and renal graft loss- 5.500 €- Source: Centro Hospitalar do Porto and UMIB/FCT

American Kidney Fund- $213 M

Description: http://annualmeeting.conferenceseries.com/upload-images/nephrologists2016-24061.png

Statistics of Physicians, Researchers and Academicians working on Nephrology

Spain

Academicians-320

Students-1200

Physicians-650

Total nephrologists-460

Description: http://annualmeeting.conferenceseries.com/upload-images/nephrologists2016-39255.png

Europe

Academicians-2500

Students-28000

Physicians-17000

Total nephrologists-8567

Description: http://annualmeeting.conferenceseries.com/upload-images/nephrologists2016-76074.png

World

Academicians-16500

Students-1,25,075

Physicians-45,650

Total nephrologists-55,545

Description: http://annualmeeting.conferenceseries.com/upload-images/nephrologists2016-42538.png

Comparison between total statistics on Nephrology members

Description: http://annualmeeting.conferenceseries.com/upload-images/nephrologists2016-97793.png

 

 

 

 

Conference Series LLC invites all the participants across the globe to attend the 16th European Nephrology Conference which is scheduled to organize on October 02-04, 2017 at Barcelona, Spain which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions.